Mark Mitchnick
About Mark Mitchnick
Mark Mitchnick: Venture Partner, CMC and Formulation
Mark Mitchnick is currently a Venture Partner focusing on CMC (Chemistry, Manufacturing, and Controls) and Formulation. His role involves extensive expertise in drug product development, leveraging a strong foundation built over years of founding and leading multiple companies within the pharmaceutical and digital health sectors.
Education and Medical Training of Mark Mitchnick
Mark Mitchnick holds a B.Sc. in Animal Sciences from Purdue University. He furthered his education by earning an M.D. from Georgetown University Medical School. His medical training includes a specialized residency in pediatrics at The New York Hospital, Cornell Medical Center. Additionally, he is a licensed acupuncturist, showcasing a diverse set of skills within the field of medicine.
Professional Background and Experience of Mark Mitchnick
Mark Mitchnick has a vast professional background, including private practice as a physician in the US and voluntary pediatric work in countries like Thailand, Cambodia, and Nicaragua. He founded three companies that achieved successful exits, including Particle Sciences, which was acquired by Lubrizol, and Mind Sciences, acquired by Sharecare. He also founded nanoparticulate zinc oxide technology for sunscreens, later acquired by BASF, and served as the CSO and a board member for the International Partnership for Microbicides.
Mark Mitchnick's Innovations and Contributions
Throughout his career, Mark Mitchnick has made notable contributions to technology and healthcare. He invented nanoparticulate zinc oxide for sunscreens and led Particle Sciences, advancing complex drug product development. His company Mind Sciences focused on digital health interventions for smoking cessation, binge eating, and anxiety, and he contributed to the development of a vaginal ring for HIV PrEP through the International Partnership for Microbicides. He holds over 25 patents and has published numerous peer-reviewed articles and book contributions.